Composition
Glimepiride Tablets IP
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Glimeberg contains Glimepiride, a third-generation sulfonylurea that stimulates pancreatic insulin secretion with a lower risk of hypoglycaemia than older agents.
Indication
Type 2 diabetes mellitus when diet and exercise alone are insufficient to achieve glycaemic control.
Packaging
10 x 10 Alu-Alu strip pack
Storage
Store below 25°C, protected from light.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.